4//SEC Filing
CATABASIS PHARMACEUTICALS INC 4
Accession 0001179110-16-030448
$ATXSCIK 0001454789operating
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 4:08 PM ET
Size
5.5 KB
Accession
0001179110-16-030448
Insider Transaction Report
Form 4
Nichols Andrew John
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2016-10-03+13,000→ 13,000 totalExercise: $5.79Exp: 2026-10-02→ Common Stock (13,000 underlying)
Footnotes (1)
- [F1]This option was granted on October 3, 2016 and is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of October 1, 2016 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.
Documents
Issuer
CATABASIS PHARMACEUTICALS INC
CIK 0001454789
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001454789
Filing Metadata
- Form type
- 4
- Filed
- Oct 4, 8:00 PM ET
- Accepted
- Oct 5, 4:08 PM ET
- Size
- 5.5 KB